FourThought Financial Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
FourThought Financial Partners's NVO Position: Q2 2026 in Review
FourThought Financial Partners increased its Novo Nordisk (NVO) stake by 9.3% in Q2 2026, buying an estimated $374K and bringing the position to 102,109 shares worth $4.9M. The position accounts for 0.38% of the portfolio, ranked #70.
FourThought Financial Partners first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- FourThought Financial Partners held 102,109 shares of Novo Nordisk worth $4.9M as of Q2 2026.
- FourThought Financial Partners bought 8,710 Novo Nordisk shares in Q2 2026, an estimated $374K.
- Novo Nordisk made up 0.38% of FourThought Financial Partners's portfolio in Q2 2026, its #70 holding.
- FourThought Financial Partners first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
- 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on FourThought Financial Partners's 13F filing for Q2 2026, filed 12 Aug 2026.